Immune-mediated oral mucosal pathology: a comprehensive review and update for clinicians Part I

• Published in: Italian Journal of Dermatology and Venereology
• Main Author: Alrashdan M.S.; Arzmi M.H.; Ahmad Kamil W.N.; Kawas S.A.L.; Leao J.C.
• Format: Review
• Language: English
• Published: Edizioni Minerva Medica 2023
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85175769833&doi=10.23736%2fS2784-8671.23.07676-4&partnerID=40&md5=9de5da86fe923d6d90cbb996daf6ce5b

The oral mucosa can be involved in a wide variety of mucocutaneous conditions that may present primarily in the mouth or affect other cutaneous or mucosal sites. Many of these conditions are immune mediated and typically present as inflammatory mucosal pathology. Patients experiencing such conditions usually seek medical evaluation and treatment due to the associated pain and discomfort and occasionally taste disturbance or dysphagia and the overall deterioration in the oral health-related quality of life. These conditions share some common features and there could be some overlapping in their clinical presentation, which can lead to delays in diagnosis and proper management of patients. Clinicians dealing with such disorders, including dermatologists, need to be aware of the oral manifestations of mucocutaneous conditions, their clinical features, underlying mechanisms, diagnostic approaches, and treatment options, as well as the recent advances in the research on these conditions. This review provides a comprehensive, evidence-based reference for clinicians, with updated insights into a group of immune mediated conditions known to cause oral mucosal pathology. Part one will cover oral lichen planus, erythema multiforme and systemic lupus erythematosus, while part two will cover pemphigus vulgaris and mucous membrane pemphigoid, recurrent aphthous stomatitis, in addition to the less common disorders linear IgA disease, dermatitis herpetiformis and epidermolysis bullosa. © 2023 EDIZIONI MINERVA MEDICA.